Equity · Healthcare
SNSE
Sensei Biotherapeutics Inc · NGM
Price · Chart
This price chart is drawn by TradingView, from their own data, in an embed loaded from their servers. We hold too few licensed daily closes of our own for SNSE to draw a line in its place.
The chart above plots the price of SNSE over the range selected — one day to the full history — drawn by TradingView from their own data.
SNSE insider trades
Open-market buys
0
Open-market sells
2
Net sold
$1.00M
Non-trade filings
0
Date
Insider
Type
Shares
Value
01 Jun 2026
Cambrian BioPharma Inc
10% Owner
Sell
25,000
$501K
01 Jun 2026
Peyer James
10% Owner
Sell
25,000
$501K
SNSE earnings
Date
Period
EPS
Revenue
31 Mar 2026
Q1 2026
$-131.45
—
31 Dec 2025
FY 2025
$-16.72
—
30 Sep 2025
Q3 2025
$-3.62
—
30 Jun 2025
Q2 2025
$-3.91
—
31 Mar 2025
Q1 2025
$-5.45
—
31 Dec 2024
FY 2024
$-24.01
—
30 Sep 2024
Q3 2024
$-5.77
—
30 Jun 2024
Q2 2024
$-5.69
—
no date announced in SEC filings yet
Reported figures & scheduled dates · SEC EDGAR filings
SNSE institutional holders
5 of the 45 institutional funds we track reported a SNSE position for the quarter ended 30 Jun 2026 — a combined $64.2M; the latest of those filings landed 14 Aug 2026.
Fund
Action
Shares
Value
Source: SEC EDGAR 13F filings